Merck
Everything filed under sponsors in our medical research coverage, the 3 reports filed on it so far.
Akeso's Ivonescimab Shows Lung Cancer Survival Edge
Akeso and Summit Therapeutics report their bispecific antibody ivonescimab helped lung cancer patients live longer than those on Merck's Keytruda.
mRNA cancer vaccine trial succeeds
A personalized mRNA vaccine for melanoma from Moderna and Merck has shown clinical success.
Moderna-Merck Cancer Vaccine Shows Promise in Phase 3 Melanoma Trial
Moderna and Merck's individualized cancer vaccine shows promise in Phase 3 trial for melanoma.